ArticleOncology letters2022

Thyroid dysfunction during PD-1 inhibitor treatment in patients with cancer: Incidence and association with progression-free survival.

Yanfei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.